Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland
Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland (ESTIMATE): Evaluation of a Prediction Rule
Sponsor: Cantonal Hospital of St. Gallen
A observational or N/A phase clinical study on Venous Thromboembolism, this trial is completed. The trial is conducted by Cantonal Hospital of St. Gallen and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jul 2023 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Dec 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cantonal Hospital of St. Gallen
- Insel Gruppe AG, University Hospital Bern
- Kantonsspital Baden
- Luzerner Kantonsspital
- Sanofi
- University Hospital, Geneva
- University of Zurich
For direct contact, visit the study record on ClinicalTrials.gov .